Anthracycline-induced cardiotoxicity: A case report and review of literature

BACKGROUND: Doxorubicin and other anthracycline derivatives inhibit topoisomerase II and is an important class of cytotoxic chemotherapy in cancer treatment. The use of anthracycline is limited by dose-dependent cardiotoxicity, which may manifest initially as asymptomatic cardiac dysfunction with su...

Descripción completa

Detalles Bibliográficos
Autores principales: Chong, Esther G, Lee, Eric H, Sail, Reena, Denham, Laura, Nagaraj, Gayathri, Hsueh, Chung-Tsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821007/
https://www.ncbi.nlm.nih.gov/pubmed/33552401
http://dx.doi.org/10.4330/wjc.v13.i1.28

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821007/
https://www.ncbi.nlm.nih.gov/pubmed/33552401
http://dx.doi.org/10.4330/wjc.v13.i1.28

Ejemplares similares